Compassionate Use of ASTX295 in an Individual Patient with Dedifferentiated Liposarcoma Cancer
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 participants needed
1 Location
Brief description of study
See Attached Submission Documents See Attached Submission Documents See Attached Submission Documents
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
01 Aug 2024.
Study ID: 856402
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
